Melatonin in Alzheimer’s Disease
Open Access
- 12 July 2013
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (7), 14575-14593
- https://doi.org/10.3390/ijms140714575
Abstract
Alzheimer’s disease (AD), an age-related neurodegenerative disorder with progressive cognition deficit, is characterized by extracellular senile plaques (SP) of aggregated β-amyloid (Aβ) and intracellular neurofibrillary tangles, mainly containing the hyperphosphorylated microtubule-associated protein tau. Multiple factors contribute to the etiology of AD in terms of initiation and progression. Melatonin is an endogenously produced hormone in the brain and decreases during aging and in patients with AD. Data from clinical trials indicate that melatonin supplementation improves sleep, ameliorates sundowning and slows down the progression of cognitive impairment in AD patients. Melatonin efficiently protects neuronal cells from Aβ-mediated toxicity via antioxidant and anti-amyloid properties. It not only inhibits Aβ generation, but also arrests the formation of amyloid fibrils by a structure-dependent interaction with Aβ. Our studies have demonstrated that melatonin efficiently attenuates Alzheimer-like tau hyperphosphorylation. Although the exact mechanism is still not fully understood, a direct regulatory influence of melatonin on the activities of protein kinases and protein phosphatases is proposed. Additionally, melatonin also plays a role in protecting the cholinergic system and in anti-inflammation. The aim of this review is to stimulate interest in melatonin as a potentially useful agent in the prevention and treatment of AD.This publication has 134 references indexed in Scilit:
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the LiteratureJournal of Neuropathology and Experimental Neurology, 2012
- CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell deathJournal of Neurochemistry, 2011
- Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell deathFree Radical Biology & Medicine, 2011
- Hydrogen peroxide inhibits mTOR signaling by activation of AMPKα leading to apoptosis of neuronal cellsLaboratory Investigation, 2010
- The genetics of ageingNature, 2010
- The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-α toxicity involves membrane melatonin receptorsJournal of Pineal Research, 2010
- Melatonin and Bright‐Light Treatment for Rest–Activity Disruption in Institutionalized Patients with Alzheimer's DiseaseJournal of the American Geriatrics Society, 2008
- CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degenerationJCI Insight, 2007
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature, 2004
- Fibrillogenesis of Alzheimer Aβ peptides studied by fluorescence energy transferJournal of Molecular Biology, 1997